Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.160
-0.040 (-1.82%)
Nov 21, 2024, 3:52 PM EST - Market closed
Lexaria Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 |
Market Capitalization | 38 | 8 | 18 | 35 | 31 | 54 | |
Market Cap Growth | 733.96% | -51.77% | -50.18% | 13.53% | -42.60% | -63.99% | |
Enterprise Value | 30 | 5 | 10 | 27 | 29 | 52 | |
Last Close Price | 2.20 | 1.05 | 2.96 | 6.22 | 10.38 | 20.70 | |
PS Ratio | 56.11 | 37.56 | 68.97 | 48.92 | 98.93 | 243.74 | |
PB Ratio | 3.44 | 3.17 | 2.31 | 2.71 | 12.55 | 21.78 | |
P/TBV Ratio | 5.21 | 3.29 | 2.36 | 2.74 | 13.95 | 25.62 | |
EV/Sales Ratio | 72.16 | 21.58 | 39.44 | 37.19 | 92.55 | 235.09 | |
Debt / Equity Ratio | 0.01 | 0.06 | 0.01 | 0.01 | 0.06 | - | |
Asset Turnover | 0.05 | 0.04 | 0.02 | 0.09 | 0.11 | 0.09 | |
Inventory Turnover | - | - | 2.11 | 2.39 | 0.81 | 0.28 | |
Quick Ratio | 55.84 | 6.17 | 32.79 | 78.90 | 7.20 | 8.79 | |
Current Ratio | 58.27 | 8.22 | 35.96 | 81.18 | 8.53 | 9.86 | |
Return on Equity (ROE) | -70.66% | -130.18% | -71.35% | -73.16% | -166.85% | -170.47% | |
Return on Assets (ROA) | -38.21% | -74.81% | -39.21% | -44.17% | -94.23% | -97.68% | |
Return on Capital (ROIC) | -41.33% | -77.59% | -39.70% | -44.99% | -101.11% | -102.25% | |
Earnings Yield | -12.63% | -78.45% | -41.27% | -11.39% | -12.63% | -7.56% | |
FCF Yield | -12.21% | -69.63% | -27.98% | -11.28% | -8.41% | -6.73% | |
Buyback Yield / Dilution | -72.56% | -12.38% | -34.02% | -58.34% | -6.95% | -9.63% | |
Total Shareholder Return | -72.56% | -12.38% | -34.02% | -58.34% | -6.95% | -9.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.